Skip to main content
OpenTrials

Clinical trial condition

Glioma

Explore clinical trials studying Glioma. Study availability and eligibility vary by location and protocol.

1,022 public trials 235 recruiting studies
Refine in advanced search Browse all conditions

Glioma trial results

Active, Not Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

NCT03739372

Conditions
Astrocytoma, Cancer, Glioblastoma, +12 more
Locations
  • University of California, San Diego Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
View Trial Details
Active, Not Recruiting

Fimepinostat in Treating Brain Tumors in Children and Young Adults

NCT03893487

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +23 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

NCT05664243

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Louisville Hospital/James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

NCT04164901

Conditions
Glioma, Grade 2 Glioma, Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Oncology Center Los Angeles, California, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

NCT05561374

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +10 more
Locations
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View Trial Details

Related conditions